title: Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†.
authors: ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France.
authors: Jean-Philippe
authors: JP
authors: Collet
authors: Division of Cardiology, University Hospital, Geneva, Switzerland Marco.Roffi@hcuge.ch.
authors: Marco
authors: M
authors: Roffi
authors: Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland.
authors: Christian
authors: C
authors: Mueller
authors: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Marco
authors: M
authors: Valgimigli
authors: Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Carlo
authors: C
authors: Patrono
authors: The content of this article does not necessarily reflect the opinion of the entire Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation nor of the Committee for Practice Guidelines of the European Society of Cardiology (ESC).The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France Division of Cardiology, University Hospital, Geneva, Switzerland Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Helmut
authors: H
authors: Baumgartner
authors: The content of this article does not necessarily reflect the opinion of the entire Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation nor of the Committee for Practice Guidelines of the European Society of Cardiology (ESC).The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France Division of Cardiology, University Hospital, Geneva, Switzerland Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Oliver
authors: O
authors: Gaemperli
authors: The content of this article does not necessarily reflect the opinion of the entire Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation nor of the Committee for Practice Guidelines of the European Society of Cardiology (ESC).The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France Division of Cardiology, University Hospital, Geneva, Switzerland Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Jose Luis
authors: JL
authors: Zamorano
keywords: Acute cardiac care; Acute coronary syndrome; Angioplasty; Anticoagulation; Antiplatelet; Apixaban; Aspirin; Atherothrombosis; Bivalirudin; Bypass surgery; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; European Society of Cardiology; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Stent; Ticagrelor; Unstable angina